Yann-Gaël Gangloff

5PUBLICATIONS
15CO-AUTHORS
Neurology and neuromuscular diseasesMedical infection agents (incl. prions)Energy generation, conversion and storage (excl. chemical and electrical)Haematological tumoursMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 02, 2026
Combining SMN2 splicing modifiers with HDAC6 inhibition improves spinal muscular atrophy outcomes.

|Apr 28, 2025
Muscle mTOR controls iron homeostasis and ferritinophagy via NRF2, HIFs and AKT/PKB signaling pathways.

Agnès Conjard-Duplany, Alexis Osseni, Aline Lamboux

|Nov 19, 2022
Pharmacological inhibition of HDAC6 improves muscle phenotypes in dystrophin-deficient mice by downregulating TGF-β via Smad3 acetylation.

Alexis Osseni, Aymeric Ravel-Chapuis, Edwige Belotti

|Jul 31, 2021
The ESCRT-0 subcomplex component Hrs/Hgs is a master regulator of myogenesis via modulation of signaling and degradation pathways.

L Coudert, A Osseni, Y G Gangloff

|Nov 22, 2018
Lack of muscle mTOR kinase activity causes early onset myopathy and compromises whole-body homeostasis.

Qing Zhang, Agnès Duplany, Vincent Moncollin

Pageof 1

Frequent Collaborators

4 joint publications

Laurent Schaeffer

3 joint publications

Alexis Osseni

3 joint publications

Pascal Leblanc

1 joint publications

L Coudert